Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate
Zietman, A.L., Tibbs, M.K., Dallow, K.C., Smith, C.T., Althausen, A.F., Zlotecki, R.A., Shipley, W.U.
Published in Radiotherapy and oncology (01.08.1996)
Published in Radiotherapy and oncology (01.08.1996)
Get full text
Journal Article